MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-17-0010551
Reskon Pharmaceutical Private Limited
Reskon Pharmaceutical Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹33.22 Lakh
▲ 71% YoY
Net profit · FY 2024
₹31,256
Net margin 0.9%
EBITDA · FY 2024
₹61,656
EBITDA margin 1.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Reskon Pharmaceutical Private Limited
Data last updated:
Reskon Pharmaceutical Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2017PTC302433. Its GSTIN is 27AAICR6490A1ZB (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Brijabala Deenanath Shukla and Rupesh Kumar Mishra.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shop No. 40 Sunshine Commercial Complex Nallasopara (E), Thane, Maharashtra, India – 401209.
As per the financials filed for FY 2024, the company reported a revenue of ₹33.22 Lakh, a growth of 71% compared to the previous year. For the same year it recorded a net profit of ₹31,256 (net margin 0.9%) and EBITDA of ₹61,656 (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 81% over three years and 34% over five years.
Reskon Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0010551). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909MH2017PTC302433
Registration Number 302433
Incorporation Date 04 December 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-17-0010551
Recognitions & Rankings of Reskon Pharmaceutical
Contact details
Reskon Pharmaceutical Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No. 40 Sunshine Commercial Complex Nallasopara (E), Thane, Maharashtra, India – 401209
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Reskon Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Reskon Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Reskon Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Reskon Pharmaceutical Private Limited, buy the company report.
Financials of Reskon Pharmaceutical Private Limited
FY 2024 filings availableReskon Pharmaceutical Private Limited reported revenue of ₹33.22 Lakh (up 71% YoY) for FY 2024.
Revenue · FY 2024
₹33.22 Lakh ▲ 71%
Net profit · FY 2024
₹31,256 margin 0.9%
EBITDA · FY 2024
₹61,656 margin 1.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 71%
3 years · compounded
▲ 81%
5 years · compounded
▲ 34%
EBITDA CAGR growth
1 year
▲ 113%
3 years · compounded
▲ 33%
5 years · compounded
▲ 5%
Revenue has grown at a compounded annual rate (CAGR) of 34% over five years, including 71% growth in the latest year. EBITDA rose 113% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹61,656 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹31,256 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.9% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Reskon Pharmaceutical Private Limited, buy the company report.
Board of directors of Reskon Pharmaceutical Private Limited
Reskon Pharmaceutical has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brijabala Deenanath Shukla | Director | 14 Jan 2019 | 7 Years 9 Months | Current |
| Rupesh Kumar Mishra | Director | 04 Nov 2023 | 2 Years 11 Months | Current |
Auditor
Reskon Pharmaceutical Private Limited is audited by Sharma Surendra K & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Sharma Surendra K & Co | FY 2023 | 141354W |
Shareholding
The shareholding of Reskon Pharmaceutical Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Reskon Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Reskon Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reskon Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Reskon Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICR6490A1ZB | Maharashtra | Active | 07 Jun 2018 |
To see the full GST registrations and return filing status of Reskon Pharmaceutical Private Limited, buy the company report.
Recent activity
Reskon Pharmaceutical Private Limited has 6 board changes on record since 2018: 2 appointments and 4 cessations. The latest: Abhishek Kumar Dubey ceased to be Director on 07 Nov 2023.
AGM
Reskon Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Reskon Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Ceased
Abhishek Kumar Dubey ceased to be Director.
Appointed
Rupesh Kumar Mishra was appointed as Director.
Ceased
Rupesh Kumar Mishra ceased to be Director.
Ceased
Brijabala Deenanath Shukla ceased to be Additional Director.
Appointed
Brijabala Deenanath Shukla was appointed as Director.
Ceased
Deenanath Dhanushdari Shukla ceased to be Additional Director.
Incorporation
04 Dec 2017
Reskon Pharmaceutical Private Limited was registered on 04 Dec 2017 with Roc Mumbai & aged 8 years 10 months as per MCA records.
Frequently asked questions
Reskon Pharmaceutical is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 December 2017 (9+ years old) and is registered under CIN U51909MH2017PTC302433.
Reskon Pharmaceutical has 2 current directors:
- Brijabala Deenanath Shukla - Director
- Rupesh Kumar Mishra - Director
The latest financial statements of Reskon Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Reskon Pharmaceutical is 27AAICR6490A1ZB, registered in Maharashtra.
The CIN (Corporate Identification Number) of Reskon Pharmaceutical is U51909MH2017PTC302433. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reskon Pharmaceutical was incorporated on 04 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Abhishek Kumar Dubey ceased to be Director on 07 Nov 2023. Rupesh Kumar Mishra was appointed as Director on 04 Nov 2023. Rupesh Kumar Mishra ceased to be Director on 30 Oct 2022. Reskon Pharmaceutical has 6 board changes on record in total.
Yes, Reskon Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-17-0010551).
The registered office of Reskon Pharmaceutical is at Shop No. 40 Sunshine Commercial Complex Nallasopara E, Thane, Maharashtra, India – 401209.
Reskon Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.